News and Press Releases
Ascelia Pharma Successfully Meets Primary Endpoint with Strong Headline Results in Orviglance Phase 3 Study
2 May 2023 -- Malmö, Sweden -- Ascelia Pharma, a biotech focused on improving the life of people living with rare cancer conditions, today announced that liver imaging drug candidate,...
Category: Biotechnology, Pharmaceutical
Posted: May 2, 2024
Gyros Protein Technologies introduces Gyrolab Generic Rodent ADA Kit Reagents to support preclinical immunogenicity assessment
Ready-to-use kit expands range of bioanalysis kits, and enables generic detection of immune complexes in rodent samples 2 May 2024 -- Uppsala, Sweden -- Gyros Protein Technologies, a pioneer in...
Category: BioManufacturing, Drug Discovery
Posted: May 2, 2024
Gyros AB, Uppsala Science Park, SE-751, 83 Uppsala, Sweden
Rentschler Biopharma appoints Patrick Cushing as VP Operations for US subsidiary
2 May 2024 – Laupheim, Germany; Milford (MA), US; and Stevenage, UK – Rentschler Biopharma SE, a leading global contract development and manufacturing organisation (CDMO) for biopharmaceuticals, today announced that...
Category: Biotechnology, Drug Discovery
Posted: May 2, 2024
Revolutionising Patient Care: ProPharma and PBL Launch Innovative Cell & Gene Therapy Manufacturing Device
First-of-its-kind Cell Factory Box streamlines production, making advanced treatments accessible and affordable 2 May 2024 -- Raleigh, North Carolina -- ProPharma, the leading global provider of regulatory, clinical and compliance services...
Category: BioManufacturing, Clinical Trials, Drug Discovery
Posted: May 2, 2024
PSI Partners With Medidata to Expand Data-Driven Feasibility Capabilities
30 April 2024 -- Zug, Switzerland -- PSI CRO, a leading full-service, global contract research organisation (CRO), today announced a partnership with Medidata, a Dassault Systèmes company and leading provider of clinical...
Category: Clinical Trials, Drug Discovery
Posted: May 2, 2024
Nuclera eProtein Discovery system installed at leading academic institutes
11 installs successfully completed Novel platform automates and accelerates protein production, enabling scale-up to mg amount in less than 48 hours List of institutes includes, University College London, University of...
Category: BioManufacturing, Drug Discovery, Pharmaceutical
Posted: May 2, 2024
ELRIG UK Announces Profs Ijeoma Uchegbu and Marcus Schindler as Keynote Speakers at Drug Discovery 2024
Drug Discovery 2024: Connecting Minds, Transforming Science, Empowering Community will take place at ExCeL London from 2–3 October 2 May 2024 -- Cambridge, UK -- The European Laboratory Research &...
Category: Biotechnology, Drug Discovery
Posted: May 2, 2024
ELRIG (UK) Ltd. Salisbury House, Station Road, Cambridge, CB1 2LA, UK
ProBioGen: Change in Management
30 April 2024 – Berlin, Germany – Biotech Newswire – ProBioGen AGa premier Contract Development and Manufacturing Organisation (CDMO) and technology provider with extensive expertise in cell line engineering, process...
Category: Biotechnology, Drug Discovery
Posted: May 2, 2024
Barinthus Bio Names Experienced Physician, Leon Hooftman MD, as Chief Medical Officer
Dr Hooftman brings more than 25 years’ experience in international drug development including immunology, autoimmunity, haematology, oncology and infectious diseases 1 May 2024 -- Oxford, UK -- Barinthus Biotherapeutics, formerly Vaccitech, a clinical-stage biopharmaceutical...
Category: BioManufacturing, Drug Discovery
Posted: May 1, 2024
Cytomos offers sneak preview of flagship technologyat the London Biotechnology Show 2024
1 May 2024 – TechBio company Cytomos (www.cytomos.com) will be giving visitors to this year’s London Biotechnology Show a sneak preview of Celledonia – its flagship technology that utilises the...
Category: Biotechnology, Drug Discovery
Posted: May 1, 2024
Middle Wing Building University of Edinburgh Easter Bush Campus Roslin EH25 9RG Scotland
Ellipses’ next generation selective RET inhibitor EP0031/A400 cleared to start phase 2
Drug has successfully completed US Food and Drug Administration (FDA)’s End of Phase 1 data review 1 May 2024 -- London, UK -- Ellipses Pharma, a global drug development company...
Category: Biotechnology, Clinical Trials, Drug Discovery
Posted: May 1, 2024
Janssen to adopt Johnson & Johnson brand as the Company celebrates 100 years of operating in the UK
Johnson & Johnson marks new era in the UK with updated visual identity 1 May 2024 -- High Wycombe, UK -- Johnson & Johnson today announced it is updating its...
Category: Drug Discovery, Pharmaceutical
Posted: May 1, 2024
Janssen-Cilag Limited 50-100 Holmers Farm Way High Wycombe Buckinghamshire HP12 4EG
ProBioGen Announces Change in Management
30 April 2024 -- Berlin, Germany -- ProBioGen AG, a premier contract development and manufacturing organisation (CDMO) and technology provider with extensive expertise in cell line engineering, process development and GMP...
Category: BioManufacturing, Other
Posted: April 30, 2024
Immunic announces publication of extended data from phase 2 EMPhASIS Trial of vidofludimus calcium in relapsing-remitting multiple sclerosis in the peer-reviewed journal, Neurology Neuroimmunology & Neuroinflammation
– 30 mg and 45 mg Daily Doses of Vidofludimus Calcium Suppressed Development of Gadolinium-Enhancing Lesions by 78% and 74% Compared to Pooled Placebo at 24 Weeks – – Improvements...
Category: Biotechnology, Drug Discovery
Posted: April 30, 2024
Sphere Fluidics appoints Dale Levitzke as Chief Executive Officer
Dale Levitzke joins as Dr Frank F Craig, current CEO and co-founder, announces his retirement after leading the company for 14 years 30 April 2024 -- Cambridge, UK -- Sphere...
Category: Biotechnology, Other
Posted: April 30, 2024
The Jonas Webb Building, Babraham Research Campus, Babraham, Cambridge CB22 3AT, United Kingdom
